⌘K
Loading ticker…
Entrada Therapeutics, Inc. Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, Entrada Therapeutics, Inc. Common Stock (TRDA) has a 3-month relative strength percentile of 8 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 46. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 7.6%, relative volume 5.94×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
8 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
TRDA is in a stage 3 topping pattern, week 3. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -12.3% / -18.5%.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
TRDA is held by 3 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $12M notional. Top 3 carry $24M.
Top 3 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $12M |
| IWMiShares Russell 2000 ETF | 0.01% | $9M |
| VXFVanguard Extended Market ETF | 0.00% | $3M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | TRDA Jan avg: -6.14% median: -6.79% win: 25% σ: 13.99% n: 4 2022-04-12 → 2026-05-29 | TRDA Feb avg: -2.78% median: -2.46% win: 50% σ: 8.58% n: 4 2022-04-12 → 2026-05-29 | TRDA Mar avg: 0.58% median: 6.44% win: 75% σ: 16.94% n: 4 2022-04-12 → 2026-05-29 | TRDA Apr avg: -7.76% median: -11.14% win: 40% σ: 11.30% n: 5 2022-04-12 → 2026-05-29 | TRDA May avg: -4.59% median: -2.14% win: 40% σ: 29.80% n: 5 2022-04-12 → 2026-05-29 | TRDA Jun avg: 23.21% median: 12.11% win: 50% σ: 42.82% n: 4 2022-04-12 → 2026-05-29 (current) | TRDA Jul avg: 5.73% median: 9.91% win: 75% σ: 13.05% n: 4 2022-04-12 → 2026-05-29 | TRDA Aug avg: -4.02% median: -4.15% win: 25% σ: 9.56% n: 4 2022-04-12 → 2026-05-29 | TRDA Sep avg: 7.11% median: 6.69% win: 75% σ: 14.10% n: 4 2022-04-12 → 2026-05-29 | TRDA Oct avg: 18.26% median: 13.54% win: 100% σ: 19.19% n: 4 2022-04-12 → 2026-05-29 | TRDA Nov avg: 2.63% median: -1.47% win: 50% σ: 36.74% n: 4 2022-04-12 → 2026-05-29 | TRDA Dec avg: -1.58% median: -4.79% win: 50% σ: 13.19% n: 4 2022-04-12 → 2026-05-29 |